-
Download Library
Download Library
Download LibraryQuickly sort and find the exact file you need here. Send the files directly into your Shareholder Briefcase or read and right click "save target as" individual files.
Title Date Type Size 2008 Annual Report 
1.6 MB 2009 Proxy Statement 2009
353.9 KB 2009 Proxy Card Apr 13, 2009
29.0 KB Enzon_2009_PhRMA_Code_CEO_CCO_certification.pdf
30.8 KB 2007 Annual Report 2007
1.3 MB Governance and Nominating Committee 
N/A Finance and Audit Committee
N/A Compensation Committee
N/A Code of Conduct and Corporate Values
N/A California Compliance Declaration
N/A Showing 1-10 of 15 Page: 1 2 Next 10
Search
| (ENZN) NASDAQ | |||
| Last Trade | 9.20 | ||
| Change(%) |  | -0.10 | |
| Volume | 22135 | ||
| 9:13 AM - Feb 25, 2010 | |||
News
-
09-10-2009
Enzon to Present at NewsMakers...
Enzon to Present at NewsMakers in the Biotech Industry Conference
-
07-27-2009
Enzon to Release Second Quarte...
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
-
07-27-2009
Enzon to Present at BMO Focus...
Enzon to Present at BMO Focus on Healthcare Conference
-
07-23-2009
Enzon Enhances Governance with...
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director
-
12-03-2008
Enzon to Purchase a Portion of...
Enzon to Purchase a Portion of its Outstanding Debt
-
10-20-2008
Enzon Presents New Data on its...
Enzon Presents New Data on its LNA Programs
--Platform shows promise-- -
10-16-2008
Enzon To Present Data at EORTC...
Enzon To Present Data at EORTC-NCI-AACR
--New clinical data and LNA cancer target revealed-- -
09-30-2008
Enzon's New Oncaspar-IV™ Rec...
Enzon's New Oncaspar-IV™ Receives Orphan Drug Status in the EU
-- Improved version to expand global potential --
-
09-10-2009
Enzon to Present at NewsMakers...
Enzon to Present at NewsMakers in the Biotech Industry Conference
-
05-06-2009
Enzon Reaches Phase II Dose fo...
Enzon Reaches Phase II Dose for PEG-SN38
-- Composition of matter patent granted until 2027-- -
08-11-2008
Enzon Pharmaceuticals Announce...
Enzon Pharmaceuticals Announces Intention to Explore Strategic Alternatives for Specialty Pharmaceuticals Business
-- Enzon Continues to Pursue Plan to Spin-off Biotechnology Business -- -
07-02-2008
Enzon Eliminates its Remaining...
Enzon Eliminates its Remaining 2008 Debt